SY
SymBio Pharmaceuticals Limited
SYMQY · OTC
$0.56 +0.00% (+$0.00)
Market Cap ¥4.10B
P/E Ratio -
Div. Yield -
ROE 937.62%
Bulios Fair Price
$0.63
12.9% upside
Trenutna cena
$0.56
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica SYMQY trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
3/9Valuation
49 /100
Fair P/S 3.58x
P/FCF N/A
P/FFO N/A
Growth
0 /100
Declining Book val. growth 46.91%
Rev. growth 48.45%
FCF growth N/A
Profitability
22 /100
Weak FCF margin 0.00%
Op. margin 524.67%
Gross margin 73.70%
Quality
8 /100
Poor Asset turnover 0.60x
ROA 322.33%
ROIC 2,386.20%
Debt
9 /100
High Int. coverage -104.28x
Current ratio 0.75x
Net debt/EBITDA N/A
Stability
51 /100
Moderate Profitable years 0
EPS volatility 129.94%
Beta 0.53x
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o SYMQY
Online
Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
Fuminori Yoshida
Employees
91
Headquarters
Tokyo
Prihajajoči dogodki
29 OKT.
Earnings
Upcoming earnings report